Prime Medicine (PRME) Asset Utilization Ratio (2024 - 2026)
Prime Medicine's (PRME) quarterly Asset Utilization Ratio came in at 0.01 in Q1 2026, up 2.95% YoY from 0.01 in Q1 2025, and down 0.58% on a QoQ basis from 0.01 in Q4 2025.
Powered by 
Analysis
Prime Medicine (PRME) Asset Utilization Ratio (2024 - 2026) Analysis & Trends
Prime Medicine (PRME) has 3 years of Asset Utilization Ratio data on file, last reported at 0.01 in Q1 2026.
- Quarterly Asset Utilization Ratio rose 2.95% year-over-year to 0.01 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01 (up 2.95% YoY) and the FY2025 annual result came in at 0.01, up 19.17% from the prior year.
- Asset Utilization Ratio fell to 0.01 in Q1 2026, from 0.01 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.02 in Q3 2025 to a low of 0.0 in Q2 2024.
- A 3-year average of 0.01 and a median of 0.01 in 2025 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2025 — Asset Utilization Ratio soared 689.54% — and 2026, when it climbed 2.95%.
- Tracing PRME's Asset Utilization Ratio over 3 years: stood at 0.01 in 2024, then jumped by 34.49% to 0.01 in 2025, then slipped by 0.58% to 0.01 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.01 (Q1 2026), 0.01 (Q4 2025), and 0.02 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 0.20 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 0.69 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 0.90 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.13 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 0.54 |
| 10 | Prime Medicine | 653.96 Mn | 653.96 Mn | - | 0.01 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.01 |
| Mar 31, 2026 | 0.01 |
| Dec 31, 2025 | 0.01 |
| Sep 30, 2025 | 0.02 |
| Jun 30, 2025 | 0.02 |
| Mar 31, 2025 | 0.01 |
| Dec 31, 2024 | 0.01 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |